SUMMARY
The research of Herbert C. Wolfsen, M.D., centers on improving the detection and minimally invasive treatment of Barrett's esophagus, dysplasia and early esophageal cancers. Dr. Wolfsen improves endoscopic technologies to better identify precancerous changes and guide timely intervention in high-risk patient populations. This includes patients undergoing surveillance for esophageal disease.
Dr. Wolfsen investigates advanced imaging modalities, including high-definition white-light imaging, narrow band imaging and confocal endomicroscopy. He also studies emerging optical and spectroscopic techniques. Dr. Wolfsen evaluates endoscopic therapies, including mucosal resection and ablation methods such as radiofrequency ablation, photodynamic therapy and cryotherapy. By integrating imaging and treatment innovations, he shifts care toward earlier diagnosis and less invasive management while clarifying mechanisms of disease progression and treatment response.
Focus areas
- Endoscopic detection of dysplasia. Dr. Wolfsen develops and evaluates advanced imaging technologies to improve the identification of precancerous changes in Barrett's esophagus. His work addresses limitations of standard visualization methods by enhancing sensitivity and staging accuracy, which enables earlier and more precise diagnosis in surveillance populations.
- Minimally invasive treatment strategies. Dr. Wolfsen studies endoscopic therapies such as mucosal resection, radiofrequency ablation and cryotherapy for early esophageal neoplasia. His research compares safety and effectiveness across modalities to reduce reliance on surgical resection and improve patient outcomes.
- Barrett's disease progression biology. Dr. Wolfsen investigates clinical and biological factors associated with progression from Barrett's esophagus to dysplasia and cancer. Longitudinal biospecimen collection supports the identification of markers that distinguish stable from progressive disease.
- Innovative diagnostic devices. Dr. Wolfsen explores noninvasive and minimally invasive technologies, including capsule-based imaging and sponge-based sampling tools. These techniques are used to expand screening and monitoring capabilities beyond traditional endoscopy. They also are used to improve accessibility.
Significance to patient care
Barrett's esophagus can lead to esophageal cancer, which can be harder to treat if found late. Dr. Wolfsen's research helps medical teams find tissue changes earlier and treat them without major surgery.
By improving imaging tools and developing less invasive treatments, patients can get care that is safer, works better and is easier to manage. New screening tools may also help identify the disease earlier, sooner and in more people.
Together, these advances aim to prevent cancer, lower complications, and help patients live longer and have a better quality of life.